Greenwich LifeSciences, Inc.
3992 Bluebonnet Dr., Building 14
Stafford, TX 77477
| April 4, 2022 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Gary Guttenberg
| Re: | Greenwich LifeSciences, Inc. | |
| Amendment No. 1 to Form S-3 Registration Statement | ||
| Filed April 1, 2022 | ||
| File No. 333-263855 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Greenwich LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Wednesday, April 6, 2022, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| GREENWICH LIFESCIENCES, INC. | ||
| By: | /s/ Snehal Patel | |
| Name: | Snehal Patel | |
| Title: | Chief Executive Officer | |
| -1- |
